Related Experiment Video
Updated: Jul 10, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders
Animesh Pardanani1, Brooke L Fridley, Terra L Lasho
1Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. pardanani.animesh@mayo.edu
Abstract:
JAK2V617F is an acquired mutation associated with polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). We tested the hypothesis that the paradox of a single disease allele associated with 3 distinctive clinical phenotypes could be explained in part by host-modifying influences. We screened for genetic variation within 4 candidate genes involved in JAK-STAT signaling, including receptors for erythropoietin (EPOR), thrombopoietin (MPL), and granulocyte colony-stimulating factor (GCSFR), and JAK2. We genotyped 32 linkage disequilibrium tag single nucleotide polymorphism (SNP) loci in 179 white patients: 84 had PV, 58 had PMF, and 37 had ET. Genotype-phenotype analysis showed 3 JAK2 SNPs (rs7046736, rs10815148, and rs12342421) to be significantly but reciprocally associated with PV (P < .001 for all; odds ratio = 0.16, 2.72, and 2.46, respectively) and ET (P < .001 for all; odds ratio = 3.05, 0.29, and 0.30, respectively) but not with PMF. Three additional JAK2 SNPs (rs10758669, rs3808850, and rs10974947) and a single EPOR SNP (rs318699) were also significantly associated with PV but not with ET or PMF. Finally, intragene haplotypes in JAK2 were significantly associated with PV only. Thus, host genetic variation may contribute to phenotypic diversity among myeloproliferative disorders, including in the presence of a shared disease allele.
Insights
Host genetic variations influence myeloproliferative disorders. Specific JAK2 and EPOR single nucleotide polymorphisms are associated with distinct clinical phenotypes like polycythemia vera and essential thrombocythemia, but not primary myelofibrosis.
Area of Science:
- Hematology
- Genetics
- Oncology
Background:
- The JAK2V617F mutation is linked to polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF).
- The presence of a single mutation associated with diverse clinical outcomes suggests the involvement of host-modifying factors.
- Investigating genetic variations in key signaling pathways may elucidate this phenotypic variability.
Purpose of the Study:
- To test the hypothesis that host genetic variations contribute to the distinct clinical phenotypes observed in myeloproliferative disorders (MPNs) associated with the JAK2V617F mutation.
- To identify specific genetic variations within JAK-STAT signaling pathway genes that correlate with different MPN phenotypes.
Main Methods:
- Genotyping of 32 single nucleotide polymorphism (SNP) loci in JAK2, EPOR, MPL, and GCSFR genes.
- Analysis of genotype-phenotype correlations in 179 white patients with PV, PMF, or ET.
- Statistical analysis including odds ratios and p-values to assess SNP associations with specific MPN diagnoses.
Main Results:
- Three JAK2 SNPs (rs7046736, rs10815148, rs12342421) showed significant, reciprocal associations with PV and ET, but not PMF.
- Three additional JAK2 SNPs (rs10758669, rs3808850, rs10974947) and one EPOR SNP (rs318699) were associated with PV exclusively.
- Intragenic JAK2 haplotypes were significantly associated with PV, further supporting a genetic influence on disease phenotype.
Conclusions:
- Host genetic variations, particularly within JAK2 and EPOR, play a role in determining the clinical phenotype of myeloproliferative disorders.
- These genetic factors may explain the phenotypic diversity observed among patients with the shared JAK2V617F mutation.
- The findings highlight the importance of considering host genetics in understanding the pathogenesis and clinical presentation of MPNs.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic Variation
Genes exist in different versions called alleles, which...
Principles of Pharmacogenetics: Types of Genetic Variants
Mutation, Gene Flow, and Genetic Drift
Differentiation of Common Myeloid Progenitor Cells
Multiple Allele Traits
